These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28003126)

  • 1. Emerging role of Hippo signalling in pancreatic biology: YAP re-expression and plausible link to islet cell apoptosis and replication.
    Sharma A; Yerra VG; Kumar A
    Biochimie; 2017 Feb; 133():56-65. PubMed ID: 28003126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation.
    Wu Y; Qin K; Xu Y; Rajhans S; Vo T; Lopez KM; Liu J; Nipper MH; Deng J; Yin X; Ramjit LR; Ye Z; Luan Y; Arda HE; Wang P
    Elife; 2024 Jul; 13():. PubMed ID: 39051998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting Expression of Hippo Effector, Yap, for Expansion of Functional Islet Mass.
    George NM; Boerner BP; Mir SU; Guinn Z; Sarvetnick NE
    Mol Endocrinol; 2015 Nov; 29(11):1594-607. PubMed ID: 26378466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted regulation and functions of YAP/TAZ in tumors (Review).
    Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y
    Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
    J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippo Signaling Pathway in Pancreatic Cancer.
    Ansari D; Ohlsson H; Althini C; Bauden M; Zhou Q; Hu D; Andersson R
    Anticancer Res; 2019 Jul; 39(7):3317-3321. PubMed ID: 31262852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration.
    Lu L; Finegold MJ; Johnson RL
    Exp Mol Med; 2018 Jan; 50(1):e423. PubMed ID: 29303509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippo signaling regulates pancreas development through inactivation of Yap.
    George NM; Day CE; Boerner BP; Johnson RL; Sarvetnick NE
    Mol Cell Biol; 2012 Dec; 32(24):5116-28. PubMed ID: 23071096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.
    Peng C; Zhu Y; Zhang W; Liao Q; Chen Y; Zhao X; Guo Q; Shen P; Zhen B; Qian X; Yang D; Zhang JS; Xiao D; Qin W; Pei H
    Mol Cell; 2017 Nov; 68(3):591-604.e5. PubMed ID: 29100056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippo signaling promotes JNK-dependent cell migration.
    Ma X; Wang H; Ji J; Xu W; Sun Y; Li W; Zhang X; Chen J; Xue L
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1934-1939. PubMed ID: 28174264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer.
    Kim Y; Jho EH
    BMB Rep; 2017 Jun; 50(6):281-282. PubMed ID: 28502290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine.
    Moya IM; Halder G
    Nat Rev Mol Cell Biol; 2019 Apr; 20(4):211-226. PubMed ID: 30546055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes.
    Wennmann DO; Vollenbröker B; Eckart AK; Bonse J; Erdmann F; Wolters DA; Schenk LK; Schulze U; Kremerskothen J; Weide T; Pavenstädt H
    Cell Death Dis; 2014 Nov; 5(11):e1519. PubMed ID: 25393475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
    Kim M; Kim T; Johnson RL; Lim DS
    Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emerging Role of the Hippo Pathway in Lung Cancers: Clinical Implications.
    Teoh SL; Das S
    Curr Drug Targets; 2017 Nov; 18(16):1880-1892. PubMed ID: 27628948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization.
    Yoo G; Kim T; Chung C; Hwang DS; Lim DS
    Biochem Biophys Res Commun; 2017 Aug; 490(3):650-656. PubMed ID: 28634071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.